WorldPing ← All news

STAT9/17/2026, 10:30:00 AM

STAT+: A biotech hedge fund births a new immunology company

STAT+: A biotech hedge fund births a new immunology company

WorldPing

Why a biotech hedge fund decided to build from the ground up a new company to develop a better, long-acting antibody treatment for atopic dermatitis.

This is a short WorldPing brief. The full report was published by STAT.

Read the full report at STAT

More coverage: all health news on WorldPing.

Related news

As Anthropic heads towards a $2 trillion IPO, some of the loudest critics are company insiders

WorldPing

Fortune

As Anthropic heads towards a $2 trillion IPO, some of the loudest critics are company insiders

"I would burn my equity to the ground in a heartbeat for a 1% higher chance we make it out of this situation alive,” wrote one researcher.

Brief by WorldPing · Original reporting by Fortune